Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: Associations with primary and post-chemotherapy tumor histology

Pharmacogenetics and Genomics

Volumn 19, Issue 10, 2009, Pages 751-759

  Kraggerud, Sigrid M ^a   Oldenburg, Jan ^a,b   Alnaes, Grethe I ^c   Berg, Marianne ^a   Kristensen, Vessela N ^c,d   Fossa, Sophie D ^a,e   Lothe, Ragnhild A ^a,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^c Institute for Cancer Research   (United States)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Glutathione S transferase; GSTM1; GSTP1; GSTT1; Polymorphism; Testicular germ cell tumor

Indexed keywords

CISPLATIN; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVOR; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENOTYPE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TERATOMA;

ADOLESCENT; ADULT; AGED; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMINOMA; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; TESTICULAR NEOPLASMS;

EID: 70349564484     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283304253     Document Type: Article

References (42)

1. Mostofi FK, Sobin LH. International Histological Classification of Tumors No. 16, Histological Typing of Testis Tumors. Geneva: World Health Organization; 1976.
2. Swerdlow AJ, Higgins CD, Pike MC. Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ 1997; 314:1507.
3. Moller H, Cortes D, Engholm G, Thorup J. Risk of testicular cancer with cryptorchidism and with testicular biopsy: cohort study. BMJ 1998; 317:729-730.
4. Forman D, Oliver RT, Brett AR, Marsh SG, Moses JH, Bodmer JG, et al. Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 1992; 65:255-262.
5. Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen AL, Fossa SD. Familial testicular cancer in Norway and southern Sweden. Br J Cancer 1996; 73:964-969.
6. Hemminki K, Li X. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer 2004; 90:1765-1770.
7. Huyghe E, Plante P, Thonneau PF. Testicular cancer variations in time and space in Europe. Eur Urol 2007; 51:621-628.
8. Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, et al. Testicular Cancer Incidence in Eight Northern European Countries: secular and Recent Trends. Cancer Epidemiol Biomarkers Prev 2004; 13:2157-2166.
9. Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 2000; 24:197-200.
10. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, et al. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet 2006; 15:443-451.
11. Rapley E. Susceptibility alleles for testicular germ cell tumour: a review. Int J Androl 2007; 30:242-250.
12. Lo HW, Ali-Osman F. Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol 2007; 7:367-374.
13. Kellen E, Hemelt M, Broberg K, Golka K, Kristensen VN, Hung RJ, et al. Pooled Analysis and Meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 2007; 165:1221-1230.
14. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, et al. Meta-and pooled analysis of gstt1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006; 164:1027-1042.
15. Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE Review. Am J Epidemiol 2002; 156:95-109.
16. Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 2003; 24:875-882.
17. Vogl FD, Taioli E, Maugard C, Zheng W, Ribeiro Pinto LF, Ambrosone C, et al. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2004; 13:1473-1479.
18. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45:51-88.
19. Vistisen K, Prieme H, Okkels H, Vallentin S, Loft S, Olsen JH, et al. Genotype and phenotype of glutathione S-transferase [micro] in testicular cancer patients. Pharmacogenetics 1997; 7:21-25.
20. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644.
21. Strohmeyer T, Klone A, Wagner G, Hartmann M, Sies H. Glutathione S-transferases in human testicular germ cell tumors: changes of expression and activity. J Urol 1992; 147:1424-1428.
22. Institoris E, Eid H, Bodrogi I, Bak M. Glutathione related enzymes in human testicular germ cell tumors and normal testes. Anticancer Res 1995; 15:1371-1374.
23. Katagiri A, Tomita Y, Nishiyama T, Kimura M, Sato S. Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer. Br J Cancer 1993; 68:125-129.
24. Klys HS, Whillis D, Howard G, Harrison DJ. Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. Br J Cancer 1992; 66:589-593.
25. Masters JRW, Thomas R, Hall AG, Hogarth L, Matheson EC, Cattan AR, et al. Sensitivity of testis tumour cells to chemotherapeutic drugs Role of detoxifying pathways. Eur J Cancer 1996; 32:1248-1253.
26. Dahl AA, Haaland CF, Mykletun A, Bremnes R, Dahl O, Klepp O, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol 2005; 23:2389-2395. (Pubitemid 46218733)
27. Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 2003; 21:1249-1254.
28. Calman FM, Peckman MJ, Hendry WF. The pattern of spread and treatment of metastases in testicular seminoma. Br J Urol 1979; 51:154-160.
29. Mead GM, Stenning SP. The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours. Clin Oncol (R Coll Radiol) 1997; 9:207-209.
30. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003; 21:3310-3317.
31. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A 1977; 74:1245-1249.
32. Kristensen VN, Andersen TI, Krikstein B, Geitvik G, Skovlund E, Nesland JM, et al. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics 1998; 8:441-447.
33. Ishimoto TM, Ali-Osman F. Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics 2002; 12:543-553.
34. Oldenburg J, Kraggerud SM, Cvancarova M, Lothe RA, Fossa SD. Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors. J Clin Oncol 2007; 25:708-714.
35. Oldenburg J, Kraggerud S, Brydoy M, Cvancarova M, Lothe R, Fossa S. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and-M1, a retrospective cross sectional study. J Translational Med 2007; 5:70.
36. Zielinska E, Zubowska M, Bodalski J. Polymorphism within the glutathione S-transferase P1 gene is associated with increased susceptibility to childhood malignant diseases. Pediatr Blood Cancer 2004; 43:552-559.
37. Hohaus S, Massini G, D'Alo' F, Guidi F, Putzulu R, Scardocci A, et al. Association between Glutathione S-Transferase Genotypes and Hodgkin's Lymphoma Risk and Prognosis. Clin Cancer Res 2003; 9:3435-3440.
38. Rajagopal R, Deakin M, Fawole AS, Elder JB, Elder J, Smith V, et al. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer. Carcinogenesis 2005; 26:2157-2163.
39. Jong Jeong H, Jin Kim H, Young Seo I, Ju Kim H, Oh GJ, Cheon Chae S, et al. Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett 2003; 202:193-199.
40. Roodi N, Dupont WD, Moore JH, Parl FF. Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res 2004; 64:1233-1236.
41. Holley SL, Fryer AA, Haycock JW, Grubb SEW, Strange RC, Hoban PR. Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis 2007; 28:2268-2273.
42. Edvardsen H, Kristensen VN, Grenaker Alnaes GI, Bøhn M, Erikstein BR, Helland A, et al. Germline glutathione S-transferase variants in breast cancer: Relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy. Int J Radiat Oncol Biol Phys 2007; 67:1163-1171.